One theory is that obesity might be associated with increased proliferation of tumor cells in patients with hormone receptor-positive/HER2-negative tumors, enhancing their chemotherapy susceptibility due to hormonal proliferation stimuli from increased adipose tissue. This evidence concerns the gene NR4A1 and obesity disorder.